ClinicalTrials.gg
Sign In

Paresis clinical trials

The registry lists 468 studies for Paresis across more than 10 countries. 117 are recruiting or about to start. 109 of them are mainly about Paresis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Paraparesis too: 473 studies, 119 open.

Get an email when these change. Save the Paresis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
250
Recruiting
83
Status unknown
49
Not yet recruiting
29
Terminated
28
Active, not recruiting
16

Phase

Phase 2
32
Phase 1
23
Phase 3
8
Early Phase 1
6
Phase 4
4

Where

United States
198
Italy
25
France
24
Spain
21
Turkey
18
Israel
12

Who runs them

MetroHealth Medical Center (9) · VA Office of Research and Development (9) · Ohio State University (9) · University of Alabama at Birmingham (8) · University of Minnesota (6) · IRCCS San Raffaele Roma (6) · Danderyd Hospital (6) · Medical University of South Carolina (5)

What is being tested here

Drugs under test in Paresis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Psilocybin101
Cyproheptadine001
Modafinil001
Botulinum toxin type A001
Ropinirole001
Ropivacaine001
Bupivacaine001
Doxycycline001
Lidocaine001
Triamcinolone Acetonide001

Coming up

2phase 3 studies under way
42studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 83 Paresis studies recruiting now, 34 (41%) set no upper age limit and 27 (33%) stop at 75 or younger. 10 (12%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 15 (18%) take healthy volunteers.

Recruiting studies that take each age, of 83
AgeWomenMen
106 (7%)6 (7%)
1854 (65%)54 (65%)
3065 (78%)65 (78%)
4072 (87%)72 (87%)
5075 (90%)75 (90%)
6573 (88%)73 (88%)
7567 (81%)67 (81%)
8543 (52%)43 (52%)

Across all 468 studies, recruiting or not: 31% stop at 75 or younger and 17% at 65; 15% take children; 0% are for women only and 0% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Paresis studies take

Of 239 interventional studies with no phase under Paresis, half reached primary completion within 32 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase32 mo13–55 · 239 studies—31 mo13–55 · 221 studies
Observational39 mo21–68 · 22 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Results posted1

Stopped1

Newly registered7

Show 2 more

Studies

Recruiting first, then most recently updated. Showing 50 of 468. Browse all 468 → or search them.